HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays.

HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays.

Several serological assays have been developed to detect antibodies elicited against infections with oncogenic human papillomavirus (HPV) type 16. The association between antibody levels measured by various assays and subsequent HPV infection risk may differ. We compared HPV16-specific antibody leve...

Full description

Bibliographic Details
Main Authors: Shih-Wen Lin, Arpita Ghosh, Carolina Porras, Sarah C Markt, Ana Cecilia Rodriguez, Mark Schiffman, Sholom Wacholder, Troy J Kemp, Ligia A Pinto, Paula Gonzalez, Nicolas Wentzensen, Mark T Esser, Katie Matys, Ariane Meuree, Wim Quint, Leen-Jan van Doorn, Rolando Herrero, Allan Hildesheim, Mahboobeh Safaeian, Costa Rican Vaccine Trial Group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3534652?pdf=render

Internet

http://europepmc.org/articles/PMC3534652?pdf=render

Similar Items